The health care industry could profit by helping policyholders pay for cancer treatments that prolong life, USC School of Pharmacy professors Dana P. Goldman and Darius Lakdawalla write in “Health Care’s Killer App: Life Insurance,” an op-ed in the March 20 edition of the Wall Street Journal.
“At the time of a cancer diagnosis, the incentives of the patient and those of his life insurer align more strongly,” Goldman and Lakdawalla write. “Both want him to live as long as possible. Every month of added life is a bonus for the insurer, both in postponing benefits and in collecting additional premiums.”
Read the full article here.